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Background: Cancer stem cells (CSCs), responsible for cancer metastasis and
recurrence, are generated from non-CSCs after chemo-radiation therapy. This study
investigated the induction of CSC potential in non-stem breast cancer cells and the
underlying molecular mechanisms in detachment culture.
Methods: Bulk breast cancer cells, or sorted non-CSCs and CSCs were cultured under
an attached or detached condition to assess CSC numbers, ability to form tumor
spheres, expression of stemness markers, and chemoresistance. Lentivirus carrying
CD147 shRNA or cDNA was used to manipulate CD147 expression, while CD147
ligand recombinant cyclophilin A (CyPA) or its inhibitor was used to activate or inhibit
CD147 signaling.
Results: Detachment promoted anoikis resistance, chemoresistance, sphere formation,
self-renewal, and expression of stemness markers in breast cancer cells. Detachment
increased functional ALDH+ or CD44highCD24−/low CSCs, and induced CSC potential
in ALDH− or CD44lowCD24high non-CSCs. Upon detachment, both CD147 expression
and CyPA secretion were enhanced, and CyPA-CD147 activation mediated detachment
induced CSC potential in non-CSCs via STAT3 signaling. Clinically, CD147 and pSTAT3
were highly co-expressed and correlated with poor overall survival and tumor recurrence
in breast cancer patients.
Conclusion: This study demonstrates that detachment induces the generation of
CSCs from non-stem breast cancer cells via CyPA-CD147 signaling, indicating that
targeting CD147 may serve as a potential novel therapeutic strategy for lethal metastatic
breast cancer by eliminating induced CSCs.
Keywords: breast cancer, detachment culture, induced cancer stem cells, CD147, CyPA
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INTRODUCTION
Breast cancer is the most commonly diagnosed cancer in women
and the sixth leading cause of cancer-related deaths in Chinese
women (Li et al., 2016). Approximately 80% of breast cancer-
related deaths are due to cancer metastasis to distant organs,
like the lung, bone, liver, or brain (Quaglino et al., 2020). To
date, surgery is still the most effective treatment option to cure
localized breast cancer, and chemo-radiotherapy shows efficacy
for shrinking tumors; however, both treatment strategies fail to
eradicate tumor metastasis. Thus, there is an urgent unmet need
to develop novel and more effective strategies to control breast
cancer metastasis.
Cancer cells can spread in the early stage of disease, such
as cancer in situ or precancerous lesions, while clinically visible
cancer metastasis usually occurs over time, typically 5–20 years
(Visvader and Lindeman, 2012). In an experimental mouse
model, the majority of injected metastatic cancer cells were
shown to undergo apoptosis within 2 days and only 0.02% of
cancer cells were able to form macro-metastases (Oskarsson
et al., 2014; Celia-Terrassa and Kang, 2016). It is estimated that
millions of cancer cells are released from a primary tumor mass
into the circulation system daily; however, only a few of these
cells can survive and successfully form metastatic lesions. This
small portion of cancer cells are referred to as cancer stem cells
(CSCs), which possess the ability to initiate tumor formation
and growth or to initiate tumor metastasis and recurrence in
patients (Batlle and Clevers, 2017; Clarke, 2019). Numerous
reports have provided evidence that CSCs exist in the blood
and solid tumor, and breast CSCs were among the earliest
reported CSCs isolated from solid tumors (Al-Hajj et al., 2003).
Breast CSCs were found to have higher specific cell surface
antigen CD44 expression but no or lower CD24 expression, or to
have higher aldehyde dehydrogenase 1 (ALDH1) activity (Celia-
Terrassa and Kang, 2016; Cortes-Hernandez et al., 2019). Besides
their tumorigenicity capability, breast CSCs exhibit enhanced
in vitro invasiveness and in vivo metastasis compared with non-
CSCs; and high numbers of CSCs have been associated with
poor prognosis and distant metastasis in breast cancer patients
(Pece et al., 2010).
Recently, it has become commonly accepted that not all
CSCs have an equal capability to initiate metastasis, and
that only a subset of CSCs, named as metastatic stem cell
(MetSC) (Oskarsson et al., 2014) or metastasis-initiating cells
(MICs) (Celia-Terrassa and Kang, 2016), possesses the ability
to settle metastatic colonies in secondary organs. Beside
inherited CSC potential, including self-renewal, differentiation,
and tumorigenicity, MICs may acquire additional properties,
such as resistance to anoikis, which is a detachment induced
apoptosis that serves as the first major challenge and a critical
barrier to metastasis. These properties provide the cells with
a chance to survive in the circulation and form metastasis
(Peitzsch et al., 2017). Moreover, MICs may have evolved from
a subpopulation of circulating tumor cells (CTCs, cancer cells
detached from a solid tumor mass into the blood circulatory
system) by undergoing epithelial to mesenchymal transition
(EMT) and obtaining induced stem cell-like potential, which
provides them an extraordinary advantage to suppress anoikis
and seed a metastatic lesion (Pece et al., 2010; Gkountela
and Aceto, 2016; Peitzsch et al., 2017). In breast cancer CTC
populations, the existence of CD44+Met+CD47+MICs has been
reported (Pece et al., 2010).
Thus, MICs with both CSC potential and anoikis resistance
properties are likely driven by epigenetic changes and subsequent
induction under extreme stress conditions, like detachment
from the extracellular matrix (ECM) during dissemination
(Peitzsch et al., 2017). Hypomethylation regions enriched with
transcription factor binding sites for stemness genes, such as
OCT4, NANOG, and SOX2, were identified in metastasis-prone
CTC clusters (Gkountela et al., 2019). However, it remains
unclear how the CTC epigenetic status or the induced CSC
potential is established under the ECM detached condition.
Therefore, to discover a novel anti-metastasis strategy against
MICs, research exploring the impact of detachment on CSC
potential and the corresponding molecular mechanisms is
urgently needed. Furthermore, current research in the field has
mainly focused on enrichment and assessment of CSCs using the
sphere formation assay in a detached or non-adherent condition,
but only a few studies have assessed the induction of CSC
potential upon detachment.
Our previous studies demonstrated that breast cancer cells
with high CD147 expression possess more malignant phenotypes,
like cancer metastasis and recurrence, and are associated
with poor overall survival and treatment outcomes (Li et al.,
2009). CD147 promotes cancer cell invasion and metastasis by
stimulating the secretion of matrix metalloproteinase (Xu et al.,
2007b), enhancing cell motility (Zhao et al., 2011), and regulating
the interaction between cancer and stroma (Xu et al., 2013).
More importantly, CD147 expression can induce cancer cells
to acquire CSC characteristics, such as EMT (Wu et al., 2011),
anoikis resistance (Ma et al., 2010; Ke et al., 2012), and chemo-
resistance (Tang et al., 2012). In addition, we previously reported
that CD147 induces cell proliferation and invasion by activating
pSTAT3Y705 signaling via interacting with CD44s (Li et al.,
2013), while anti-CD147 inhibits CSC potential and sensitizes
cancer cells to chemoradiotherapy by blocking CD44s-pSTAT3
signaling (Fan et al., 2019). In view of the role of CD147 in
CSCs and anoikis resistance, we hypothesized that CD147 may
be involved in the induction of breast CSC features under a
detached condition.
We performed a systematic study to explore the impact
of detachment on the potential of breast CSCs and the
underlying cellular and molecular mechanisms. Our findings
provide a promising therapeutic strategy to prevent breast cancer
metastasis through disrupting detachment induced CSC potential
via targeting CD147.
MATERIALS AND METHODS
Cell Lines and Constructs
Human breast cancer T-47D, MCF7, and MDA-MB-231 cell
lines were originally purchased from the American Type Culture
Collection (Manassas, VA, United States) and cultured in Roswell
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Park Memorial Institute-1640 medium (RPMI-1640; HyClone,
Logan, UT, United States) supplemented with 10% fetal bovine
serum (FBS, HyClone) in a humidified incubator with 5%
CO2 at 37◦C. All cell lines were tested for mycoplasma and
characterized by short tandem repeat (STR) profiling analysis
(Cenvino, Beijing, China).
The pGIPZ empty vector, pGIPZ-CD147, and pLKO.1-
CD147 lentiviral shRNA constructs were obtained from Open
Biosystems (Lafayette, CO, United States). The MISSION R© Non-
Target shRNA control vector (pLKO.1-NTC) was obtained
from Sigma Chemicals. CD147 overexpressed construct was
established by subcloning human CD147 cDNA into the GV341
lentiviral expression vector (Genechem, Shanghai, China).
Establishment of Stable Cell Sublines
The lentivirus carrying CD147 shRNA (untagged pLKO CD147-
shRNA, GFP tagged pGIPZ CD147-shRNA) or negative control
shRNA, carrying CD147 cDNA or control vector was infected
into breast cancer cells, and the stable cell subclones were selected
by adding culture medium containing 3–6 µg/ml of puromycin.
CD147 expression levels were analyzed using flow cytometry
and immunoblotting.
Tumorsphere Culture and Passaging
Cells were suspended in Dulbecco’s modified Eagle’s medium/F12
(DMEM/F12, HyClone) serum-free medium containing 1%
N2, 2% B27, 15% glucose (Invitrogen), 10 ng/ml human
bFGF (Sigma Chemicals), 10 ng/ml EGF (Invitrogen), 1 µg/ml
hydrocortisone (Sigma Chemicals), 5 µg/ml insulin (Sigma
Chemicals), 5 µg/ml β-mercaptoethanol (Invitrogen), 0.2%
heparin (Stem Cell Technologies, Cambridge, MA, United States)
and seeded into six-well ultra-low attachment plates (Corning,
NY, United States) in triplicate at a density of 2 × 104 cells per
well and cultured for 10–14 days to form tumor spheres, which
were quantified under an inverted microscope (Olympus). For
tumorsphere passaging, we collected spheroids with a 40 µm Cell
Strainer (Corning, San Jose, CA, United States) and disassociated
them with TrypLETM (Thermo Fisher Scientific, Waltham, MA,
United States) into a single cell suspension, and re-seeded the
viable cells into six-well ultra-low attachment plates at a density
of 2 × 104 cells per well and cultured for 10–14 days. Sphere
formation efficiency (SFE) was calculated as the percentage of
the number of spheres larger than 70 µm in the total number of
original inoculated cells.
For single cell tumorsphere formation, cells were seeded into
96-well ultra-low attachment plates (Corning) at a dilution of
approximately one cell per well and maintained for 1 month with
the tumorsphere medium refreshed every 7 days.
Anoikis Assay
Cells were seeded into 24-well ultra-low attachment plates
(Corning, detached condition) or uncoated common plates
(attached condition) at a density of 5× 104 per well and cultured
in RPMI-1640 medium containing 10% FBS for indicated periods
of time. The cells were labeled with the Annexin V-FITC and
propidium iodide (PI) double staining kit (BioLegend, San Diego,
CA, United States) according to the manufacturer’s protocol. The
labeled cells were immediately measured with a BD FACS Calibur
Flow Cytometer (BD Biosciences, San Jose, CA, United States)
and quantified with CellQuest software (BD Biosciences) for
apoptosis (anoikis) levels.
ALDEFLUOR Assay and Sorting of
ALDH± Subpopulations
The ALDEFLUOR kit (Stem Cell Technologies) was applied to
analyze the population with ALDH1 enzymatic activity according
to a previous study (Wu et al., 2016). In brief, 1 × 106 cells
were incubated in the ALDEFLUOR assay buffer containing
1 µM ALDH1 substrate BAAA at 37◦C for 45 min, whereas
negative control cells were incubated with 50 mM of ALDH
inhibitor diethylaminobenz aldehyde (DEAB) under the same
conditions. Next, the cells were resuspended in 2% FBS/Hank’s
Balanced Salt Solution (HBSS) containing 1 µg/ml 7-AAD to
exclude dead cells. The sorting gates were established using DEAB
negative cells, and positive and negative cells were sorted on a BD
FACS Aria III (BD Biosciences). The purity of sorted cells was
determined as >90% positive.
CD44+CD24− Staining and Sorting of
CD44highCD24−/low or CD44lowCD24high
Subpopulations
1 × 106 cells were incubated on ice with 200 µl of anti-
CD24-PE and anti-CD44-APC in 2% FBS/HBSS in the dark for
20 min, and the antibody labeled cells were then analyzed using
a FACS Calibur Flow Cytometer. The isotype-matched mouse
immunoglobulin was used as a negative control. For cell sorting,
cells were stained with the indicated antibodies and suspended
in 2% FBS/HBSS with 1 µg/ml 7-AAD for gating viable cells.
Positive and negative cells were sorted on a BD FACS Aria III.
The purity of sorted cells was determined as >90% positive.
Patient Samples and Tissue Microarray
A total 138 breast cancer patients who were hospitalized between
June 2007 and August 2016 were included in this retrospective
study. Patients’ survival data were recorded for 26–132 months.
All patients (100%) underwent primary surgical interventions.
The median age of patients was 54 years (range 29–87 years).
Clinicopathological data were collected from patients’ medical
records, which included age of patients at diagnosis, tumor type
and grade, TNM stage, AJCC stage, patient survival, recurrence
time, and the expression of Her-2, ER, PR, P53 (Table 1).
This study was approved by the Institutional Review Board of
the Air Force Medical University. A tissue microarray (TMA)
constructed from paraffin-embedded tissue blocks from above
138 patients was purchased from the National Engineering
Center for Biochip (Shanghai, China). The study protocol was
approved by the ethics committee of The Fourth Military Medical
University (KY20183305-1).
Immunohistochemistry
The TMA sections were immunostained according to a standard
staining procedure described previously (Li et al., 2013). Mouse
or rabbit IgG was used as a negative control. The percentage
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TABLE 1 | Characteristics of breast cancer patients.
Clinical features # Patients (%)
Age, year































Mean, median (range) 100.7, 119 (10–132)
No 100 (72.5)













*Only 137 cases with available tumor type data #Available data detected.
and intensity of staining was independently scored by two
pathologists in a blinded manner. The staining intensity was
scored for four categories: 0 (no visible staining), 1 (light
brown staining), 2 (medium brown staining), and 3 (dark brown
staining), with the same intensity covering more than 75% of the
stained area. CD147 staining was scored as negative (no positivity
at all); weak (1 + positivity regardless of positive cell percentages
or 2 + positivity of ≤30% of cells); moderate (2 + positivity of
>30% of cells or 3 + positivity of ≤50% of cells); and strong (3+,
positivity of >50% of cells). pSTAT3 staining was classified as
negative (no staining); weak (1 + staining in ≤50% of cells or
2 + staining in ≤25% of cells); moderate (1 + staining in >50%
of cells, 2 + staining in 26–75% of cells or 3 + staining in ≤25%
of cells); strong (2 + staining in >75% of cells or 3 + staining
in >25% of cells) (Li et al., 2009, 2013). For data analysis, the
immunostained TMA-sections were divided into two groups of
low- vs. high-expression. The low-expression group included
cases with intensity scores indicating negative and weak staining,
whereas the high-expression group included cases with intensity
scores indicating moderate and strong staining.
Statistical Analysis
All data are expressed as mean ± standard deviation (SD) of
three independent experiments. An independent Student’s t-test
or one-way ANOVA was performed to compare the continuous
variables between the two groups or more than two groups,
respectively, while the categorical variables were analyzed using
the χ2 test. The Kaplan–Meier method and the log-rank test
were used to compare overall survival, defined as the time from
a patient’s surgery until death, and recurrence survival, defined
as the time of patients having recurrence until death. Patients
who survived were censored at the time of their last follow-up.
The Cox’s proportional hazards model was used to analyze the
association of CD147 and/or pSTAT3 expression with patient
survival/recurrence for the independent prognostic predictors.
All statistical analyses were carried out with SPSS 22.0 (IBM)
and Prism 6.0 software (GraphPad). ∗P < 0.05, ∗∗P < 0.01, and
∗∗∗P < 0.001 compared with the control group.
RESULTS
Detachment Promotes CSC Features of
Breast Cancer Cells
To detect the effect of detachment culture on induction of CSC
potential, we first determined the ability of breast cancer cells
to resist anoikis. As compared with cancer cells cultured under
the attached condition, we found that cancer cells grown under
the detached condition exhibited different degrees of apoptosis
(Figure 1A). The detached MDA-MB-231 cells showed slight
alterations in the apoptotic ratio compared with those of cells
grown under the attached condition; however, both T-47D and
MCF7 cells showed notable apoptosis on Day 3, which gradually
reduced until Day 7, with 76–90% of cells surviving the detached
condition. In the following experiments, we selected Day 3 as the
cutoff time point for anoikis induction and Day 7 as the cut-off
time point for cell survival (anoikis resistance).
Compared with the adherent (Ad) cells, anoikis resistant
(AR) cells had a restoration of cell growth after 1–4 days
of latent phase with varying degrees of prolonged doubling
time (Td, Figure 1B). The reduced AR cell growth coincided
with a higher proportion of cell in the G1-phase (Figure 1C
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FIGURE 1 | Detachment promotes CSC features of breast cancer cells. (A) Apoptosis analysis in breast cancer cells cultured under an attached condition in a
common uncoated plate or a detached condition in ultra-low attachment plate for up to 12 days. (B) Cell growth measurement by detecting the WST-8 dye
absorbance at 450 nm in breast cancer cells cultured under an adherent (Ad) or anoikis resistant (AR) condition for 7 days and then cultured under an adherent
condition for up to 12 days. Td , doubling time. (C) Cell cycle distribution analysis in T-47D and MCF7 cells cultured under an Ad or AR condition for 7 days. (D) Cell
proliferation analysis by PKH 26 staining in T-47D and MCF7 cells cultured under an Ad or AR condition for 7 days. Unlabeled cells were choosing as a control.
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and Supplementary Figure S1A), and a significantly higher
number of PKH26 positive slow-cycling or quiescent cells
compared to the Ad cells (Figure 1D). As anoikis resistance,
slow-cycling, and quiescence are essential features of CSCs, we
hypothesized that detachment may promote the acquisition of
CSC potential in AR cells.
Detachment Increases Functional
ALDH+ or CD44highCD24−/low CSCs
To assess whether AR cells acquire CSC potential
upon detachment, we assayed the ratio of ALDH+ or
CD44highCD24−/low CSCs. As compared with that of attached
cells, detached cells had a time-dependent increase in the ALDH+
subpopulation (Figure 2A and Supplementary Figure S1B).
Under the detached condition, the ratio of CD44highCD24−/low
subpopulation increased in a time-dependent manner in the
anoikis-sensitive T-47D and MCF7 cells but not in anoikis-
insensitive MDA-MB-231 cells, which have a higher percentage
of the CD44highCD24−/low subpopulation (over 90%, Figure 2B
and Supplementary Figure S1C). We further isolated fresh
ex vivo malignant pleural effusion (MPE) cells from two breast
cancer patients and cultured cells under attached or detached
conditions for 14 days (Supplementary Figure S2A). Upon
detachment, the ratio of the ALDH+ subpopulation increased
by 1.91- and 2.12-fold in both MPE cells, while the ratio of the
CD44highCD24−/low subpopulation increased by threefold in the
MPE cells (Supplementary Figures S2B,C). These data suggest
that breast cancer cells cultured under the detached condition
have increased CSCs.
Next, we determined the influence of detachment on CSC
traits, including drug sensitivity, spherogenesis, and stemness.
Compared to those of Ad cells treated with either Doxorubicin
or Taxol, AR cells showed a significant increase of 50%
effective concentration (EC50, more than 360-fold inductions;
Figure 2C and Supplementary Figure S2D). AR cells from
the T-47D and MCF7 were capable of growing in the medium
containing Doxorubicin and Taxol, respectively. AR cells also
formed significantly more tumor spheres compared to the Ad
cells (1.66 ± 0.19 and 1.47 ± 0.30-fold increases in T-47D
and MCF7 cells, respectively, Figure 2D), and had higher
spherogenesis capacity that was maintained after the third
passage of tumorsphere culture (Figure 2E), implying that
detached culture enhanced the self-renewal potential of CSCs.
Moreover, AR cells expressed a significantly higher level of
stemness genes like OCT4 and SOX2 compared to the Ad cells
(Figure 2F). These results demonstrate that detachment enhances
functional CSCs in AR cells.
Detachment Induces CSC Potential in
ALDH− or CD44lowCD24high Non-CSCs
Previous studies revealed that differentiated cancer cells were
able to acquire stem cell potential under environmental stress,
such as hypoxia (Gammon et al., 2013), radiation (Peitzsch et al.,
2016; Chen et al., 2017), and chemotherapy (Hu et al., 2012).
In the following study, we explored whether non-stem breast
cancer cells acquire CSC potential under a detached condition.
We isolated non-CSCs (ALDH− or CD44lowCD24high) and CSCs
(ALDH+ or CD44highCD24−/low), cultured them under either
attached or detached conditions for 7 days, and then analyzed the
CSC ratios (Figure 3A). Our data showed that upon detachment,
both CSC and non-CSC subpopulations had significant increases
in the ratio of CSCs (Figures 3B,C). However, the fold increases
of CSC ratios were much higher in non-CSCs than in CSCs;
the average increases of CSC ratios in CD44lowCD24high non-
CSCs and in CD44highCD24−/low CSCs obtained from T-47D
cells were 7.90 ± 2.68 and 3.77 ± 2.68-fold, respectively; and
3.61 ± 1.57 and 1.90 ± 0.42-fold, respectively, for MCF-7
cells. These findings were similar to the results in the ALDH−
and ALDH+ subpopulations. Next, we isolated ALDH− non-
CSCs and ALDH+ CSCs, and cultured them under Ad or
AR conditions for tumorsphere formation and stemness gene
analysis. We found that tumorsphere formation ability and
stemness gene expression, especially SOX2 mRNA levels, were
significantly increased both in the ALDH− non-CSCs and
ALDH+ CSCs upon detachment, while OCT4 mRNA levels
were significantly increased only in the ALDH+ CSCs upon
detachment (Figures 3D,E). These data demonstrate that the
CSC phenotypes and traits can be induced from non-CSCs under
a detached condition.
CD147 Mediates Detachment Induced
CSC Potential in Non-CSCs
Our previous studies revealed that highly expressed CD147 in
breast cancer tissues is an independent prognostic predictor for
cancer recurrence and metastasis (Li et al., 2009), and CD147
induces the anoikis resistance of transformed HEK293 (Ma et al.,
2010) and liver cancer cells (Ke et al., 2012). In our current breast
cancer studies, we further confirmed that CD147 expression was
associated with the ability to resist anoikis, with AR MDA-MB-
231 cells having significantly higher CD147 expression compared
to the anoikis sensitive T-47D and MCF7 cells (Supplementary
Figures S2E,F, S3A left). Furthermore, upon detachment, CD147
protein levels were upregulated in a time-dependent manner in
all three cell lines, although CD147 mRNA levels only increased
in the T-47D and MCF7 cells (Figures 4A,B and Supplementary
Figure S3A right).
To explore the influence of CD147 on detachment-induced
CSC potential, we constructed the CD147 knockdown
(A6)/negative control (NTC) or CD147 overexpressing
(CD147)/vector control (VC) breast cancer cells and cultured
them in a detached condition. As shown in Supplementary
Figures S3B–G, effectively silencing CD147 expression (>70%)
resulted in sensitizing MDA-MB-231 cells to detachment-
induced apoptosis, while CD147 overexpression greatly enhanced
the MCF7 cells’ ability to resist anoikis. CD147 knockdown
significantly decreased tumorsphere numbers both in a passage-
dependent manner and at a single cell level (Supplementary
Figure S4A). Compared to NTC cells, CD147 knockdown
A6 cells had a much lower tumor incidence (2/8 vs. 5/8), an
increased median tumor formation time (>44 vs. 25 days),
and significantly smaller tumors (77.05–81.72% reduction
between Day 20 and Day 44, Supplementary Figure S4B).
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FIGURE 2 | Detachment increases functional ALDH+ or CD44highCD24-/low CSCs. ALDH+ (A) and CD44highCD24-/low (B) subpopulation analysis in T-47D and
MCF7 cells cultured under an attached or detached condition for 0, 1, or 3 days. (C–F) Cells were cultured under an Ad or AR condition for 7 days, and then used
for the following experiments: (C) Cytotoxicity of Doxorubicin (Dox) and Taxol (Tax) in T-47D and MCF7 cells. (D,E) Tumorsphere numbers without or with passaging
in T-47D and MCF7 cells. (F) qRT-PCR analysis of OCT4 and SOX2 mRNA levels in T-47D, MCF7, and MDA-MB-231 cells.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 October 2020 | Volume 8 | Article 543856
fcell-08-543856 October 21, 2020 Time: 10:12 # 8
Meng et al. Detachment Induces CSC Potential
FIGURE 3 | Detachment induces CSC potential in ALDH- or CD44lowCD24high non-CSCs. (A) Study design. Non-CSCs (ALDH- or CD44lowCD24high) and CSCs
(ALDH+ or CD44highCD24-/low ) were sorted from T-47D and MCF7 cells and cultured under an Ad or AR condition for 7 days, then the ratio of ALDH+ or
CD44highCD24-/low subpopulation were analyzed. Flow cytometry analysis of ALDH+ (B) and CD44highCD24-/low (C) subpopulation in non-CSCs and CSCs.
Tumorsphere formation (D) and qRT-PCR analysis (E) of OCT4 and SOX2 mRNA levels in ALDH- or ALDH+ subpopulation cultured under an Ad or AR condition for
7 days.
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FIGURE 4 | CD147 mediates detachment induced CSC potential in non-CSCs. (A) Flow cytometry analysis of membranous CD147 levels in T-47D, MCF7, and
MDA-MB-231 cells cultured under an attached or detached condition for 0, 1, and 3 days. (B) Immunoblot assay of CD147 protein levels in T-47D, MCF7, and
MDA-MB-231 cultured under an Ad or AR condition for 7 days. (C,D) ALDH+ and CD44highCD24-/low subpopulation analysis in ALDH- non-CSC subpopulation
from CD147 knock-in (CD147) and control vector (VC) cells cultured under an Ad or AR condition for 7 days. Tumorsphere numbers (E) and OCT4 and SOX2 mRNA
levels (F) in ALDH- subpopulation with or without CD147 knock-in or knockdown (A6 and NTC) cultured under an Ad or AR condition for 7 days.
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CD147 knockdown also abolished the detachment-induced
ALDH+ subpopulation (0.43-fold vs. 1.63-fold), while CD147
overexpression promoted the detachment-induced stemness by
upregulating SOX2 expression (Supplementary Figures S4C,D).
Next, we examined whether detachment-induced CD147
expression could help generate CSCs in non-CSCs. As shown in
Figures 4C,D, CD147 knock-in significantly boosted detachment
in both ALDH+ and CD44highCD24−/low subpopulation
in MCF7 ALDH− cells. Moreover, CD147 overexpression
significantly increased whereas CD147 knockdown remarkably
abolished the detachment-induced spherogenesis and stemness
in ALDH− MCF7 and MDA-MB-231 cells (Figures 4E,F).
These data suggest that CD147 is associated with CSC traits
in AR breast cancer cells, and that it plays an essential role in
detachment-induced conversion of non-CSCs to CSCs.
CyPA Induces CSC Potential in
Non-CSCs via Activating CD147
Cyclophilin A (CyPA) is a natural CD147 ligand and functions as
an autocrine/paracrine chaperone molecule to facilitate CD147
membrane expression and stabilization for CD147 activation
in cells (Zhu et al., 2015). Therefore, we explored whether
CyPA induced CSC potential in breast cancer cells that were
cultured under a detached condition. We found that the
conditioned medium of AR cells had more extracellular CyPA
(eCyPA) compared to the conditioned medium of the Ad
cells (Figure 5A and Supplementary Figure S4E). We further
found that recombinant CyPA dose-dependently increased the
CSC subpopulation, tumorsphere formation, and stemness gene
expression (Figures 5B–D and Supplementary Figure S4F).
Together, these results suggest that eCyPA induces CSC potential.
We next investigated whether the CyPA-induced CSC
potential was mediated by CD147 activation through altering
the level or activity of CD147 or CyPA. Our data showed that
knockdown of CD147 significantly restrained the CyPA induced
ALDH+/CD44+CD24−/low subpopulation and stemness
gene expression (Figures 5E,F and Supplementary Figures
S5A,B). Conversely, CyPA inhibition reduced the CD147-
overexpression increased ALDH+ and CD44+CD24−/low
subpopulations (Supplementary Figures S5C–F). More
importantly, CD147 overexpression further increased, whereas
CD147 knockdown significantly blocked the CyPA-induced
ALDH+ subpopulations and spherogenesis in ALDH− non-
CSCs (Figures 5G,H). These data support that CyPA-activated
CD147 mediates detachment-induced CSC potential in non-stem
breast cancer cells.
CD147-STAT3 Signaling Contributes to
Induced CSC Potential and Predicts Poor
Prognosis and Recurrence in Breast
Cancer Patients
We previously reported that CD147 induces cell proliferation
and invasion by activating STAT3 signaling (Li et al., 2013;
Xu et al., 2016), while others showed that STAT3 is associated
with anoikis resistance (Fofaria and Srivastava, 2015) and the
conversion of non-CSCs to CSCs (Kim et al., 2013). Thus,
we next determined the role of STAT3 signaling in CD147
mediated conversion of non-CSCs to CSCs upon detachment.
We observed that, compared to anoikis-sensitive T-47D and
MCF7 Ad cells, AR cells had upregulated protein levels of
total and phosphorylated STAT3 as well as its downstream
target Bcl-xL (Figure 6A). We also found that the detachment-
increased STAT3 signaling occurred in a CD147-dependent
manner, as CD147 overexpression or knockdown dramatically
enhanced or reduced the detachment-induced pSTAT3/Bcl-xL
level, respectively (Figure 6B and Supplementary Figure S6A).
Furthermore, the STAT3 inhibitor WP1066 significantly
attenuated the detachment-induced spherogenesis and stemness
by downregulating SOX2 protein expression in the detached
ALDH− non-CSCs (Figures 6C,D). We also found that
HAb18IgG, a CD147 antibody, significantly reversed CyPA-
induced STAT3 signaling activation, downstream SOX2/OCT4
stemness gene expression, and sphere formation in ALDH− non-
CSCs, which demonstrates that targeting CyPA-CD147 signaling
could suppress STAT3 signaling and inhibit the generation of
CSCs (Figures 6E,F). Taken together, our data indicate that
CD147 promotes detachment-induced conversion of non-CSCs
to CSCs by activating STAT3 signaling.
To investigate whether CD147-pSTAT3 signaling has a
clinicopathological connection, we correlated patient survival
and recurrence data with CD147 and pSTAT3 levels in
breast cancer tissues from 138 patients. The patients with
high cytoplasmic but not membranous CD147 expression had
poorer overall survival and tumor recurrence (Figure 6G and
Supplementary Figure S6B). The double immunofluorescence
staining showed that CD147 and pSTAT3Y705 were co-
expressed in breast cancer tissues (Supplementary Figure S6C).
Furthermore, the co-expression of CD147 and pSTAT3Y705 was
higher in detached cells than in adherent cells (Supplementary
Figure S6D). These data are consistent with our recent reports
that CD147 undergoes endocytosis, which removes membrane
proteins in the cytoplasm, releases the intracellular domains
in the nucleus, and contributes to liver cancer progression
and poor prognosis (Wu et al., 2017; Yong et al., 2019).
Moreover, cytoplasmic CD147 expression was significantly
associated with pSTAT3 expression (Spearman r = 0.184, P = 0.03;
Supplementary Figure S6E). Patients with high cytoplasmic
CD147 and pSTAT3 co-expressed tumors had worse overall
survival and tumor recurrence (Figure 6G and Table 2).
The multi-variant Cox proportional hazards analysis shows
that co-expression of cytoplasmic CD147 and pSTAT3 was an
independent predictor for poor overall survival after adjusting for
tumor type/grade, pT/pN/pM/stage, and clinical stages (hazard
ratio = 31.85; 95% confidence interval, 2.67–380.02; P = 0.006,
Table 3).
DISCUSSION
In the current study, we investigated the generation of induced
breast cancer CSCs and the underlying molecular mechanisms
under detachment culture conditions. We found that the
resistance to detachment induced anoikis was associated with
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FIGURE 5 | CyPA induces CSC potential in non-CSCs via activating CD147. (A) Supernatant CyPA levels from T-47D and MCF7 cells cultured under an attached or
detached condition for 3 days. ALDH+ subpopulation analysis (B) and tumorsphere formation (C) in T-47D and MCF7 cells cultured with or without CyPA. (D) OCT4,
SOX2, and NANOG mRNA level detection in T-47D cells cultured with or without CyPA. The ratio of ALDH+ subpopulation (E) and OCT4, SOX2, and NANOG mRNA
level (F) analysis in MDA-MB-231 A6 and NTC cells cultured with or without CyPA. (G) ALDH+ subpopulation analysis in ALDH- subpopulation from T47D CD147
and VC cells cultured with or without CyPA. (H) Tumorsphere number analysis in ALDH- subpopulation with or without CD147 knock-in or knockdown cultured with
or without CyPA. Apart from the dose-dependent tumorsphere formation assay, all cells used for the above experiments were treated with 20 ng/mL CyPA for 24 h.
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FIGURE 6 | CD147-STAT3 signaling contributes to induced CSC potential and predicts poor prognosis and recurrence in breast cancer patients. STAT3,
pSTAT3Y705, and Bcl-xL protein levels in T-47D, MCF7, and MDA-MB-231 cells (A) and MCF7-CD147/VC cells (B) cultured under an Ad or AR condition for 7 days.
α-tubulin was used as a loading control and one representative of three biological replicates is shown. STAT3, pSTAT3Y705, OCT4, and SOX2 protein levels (C) and
tumorsphere numbers (D) in ALDH- cells treated with or without 1 µM WP1066 for 24 h and then cultured under an Ad or AR condition for 7 days. STAT3,
pSTAT3Y705, OCT4, and SOX2 protein levels (E) and tumorsphere numbers (F) in ALDH- cells treated with or without 20 ng/mL CyPA and 10 µg/mL HAb18IgG for
24 h. (G) Kaplan–Meier curve analysis of overall survival and tumor recurrence time in breast cancer patients stratified by level of cytoplasmic CD147 and/or pSTAT3.
Up: Overall survival (left) and tumor recurrence time (right) in 138 patients stratified by low- vs. high CD147 expression. Down: Overall survival (left) and tumor
recurrence time (right) in 47 patients stratified by low- vs. high CD147/pSTAT3 expression. (H) A proposed working model for detachment-induces CSC potential in
non-stem breast cancer cells via CyPA-CD147-pSTAT3 signaling.
CSC characteristics, and detached culture was able to increase
functional ALDH+ or CD44highCD24−/low CSC subpopulations
and to induce CSC potential in ALDH− or CD44lowCD24high
non-CSCs. Our data further demonstrated that the expression of
CD147 and the secretion of its ligand CyPA were both enhanced
in the detachment cultured breast cancer cells or supernatants,
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Age (n, ≤ 50/ > 50 years old) 16/20 5/6 0.95
Tumor type (n, IDC/others) 32/4 10/1 1
Tumor grade (n, II/II-III + III) 26/10 5/6 0.20
pT stage (n, T1/T2 + T3) 8/28 4/7 0.58
pN stage (n, N0/N1 + N2 + N3) 18/18 5/6 1
pM stage (n, M0/M1) 33/3 11/0 0.77
AJCC stage (n, 1/2A + 2B + 3A + 3C) 5/31 0/11 0.45
Patient survival (n, alive/dead) 29/7 5/6 0.023
Recurrence (n, no/yes) 11/25 4/7 1
*Low (negative to weak expression), high (moderate to strong expression).
†Estimated by χ 2 test. Bold italic values specified in P values are statistically
significant.
TABLE 3 | The Cox proportional hazard analysis of independent predicators for
overall survival of breast cancer patients.




Age (≤50, >50 years old) 9.35 (1.22–71.64) 0.031
Tumor type (IDC, ILC + mucinous
adeno + others)
4.46 (0.32–61.18) 0.26
Tumor grade (II, II–III + III) 1.74 (0.32–9.40) 0.51
pT stage (T1, T2 + T3) 19.92 (0.80–491.57) 0.067
pN stage (N0, N1 + N2 + N3) 1.80 (0.24–13.35) 0.56
pM stage (M0, M1) 0.73 (0.036–14.63) 0.83
AJCC Stage (1, 2A + 2B + 3A + 3C) 0.73 (0.036–14.63) 0.99
Recurrence (no, yes) 11.97 (1.59–90.07) 0.016
HR, hazard ratio; CI, confidence interval. *P < 0.05. Bold italic values specified in
P values are statistically significant.
respectively, and high levels of CyPA/CD147 mediated the
conversion of non-CSCs into CSCs via activating pSTAT3
signaling. In breast cancer tissue specimens, cytoplasmic CD147
and pSTAT3 were both highly expressed, and their concurrent
expression was correlated with patient poor overall survival and
tumor recurrence. In conclusion, our study provides exciting
novel evidence that cancer cells cultured in a detached condition
acquire stemness traits via upregulating CD147 expression. This
suggests that detachment cultured non-stem cancer cells resistant
to anoikis could be a source of induced CSCs with metastatic
potential or MICs, and also indicates that targeting CD147 could
be a promising therapeutic strategy for lethal metastatic breast
cancer by eliminating induced CSCs.
In the metastasis cascade, the spread of a detached primary
tumor cells through the bloodstream as CTCs is a critical
step, and only CTCs enriched with stem-like features are
considered the precursors of metastasis lesions. Therefore, the
majority of studies have focused on the contribution of stem-
like properties in CTCs to the metastatic initiating capacity
(Gkountela and Aceto, 2016; Cortes-Hernandez et al., 2019). For
example, the study by Gkountela et al. displayed the dedication
of epigenetic regulation of stemness in detached CTC clusters
on their metastasis-prone properties (Cortes-Hernandez et al.,
2019; Gkountela et al., 2019). However, it is still not well
known how CTCs acquire stemness potential. Using patient MPE
derived cell lines and MPE cells grown in aggregates under
detached conditions as a “surrogate” model for CTC clusters
(May et al., 2018), we revealed that the CSC potential could
be induced in breast cancer cells under a detached condition.
Our current data indicate that detachment acts as a harsh
microenvironmental pressure to induce CTC stemness potential.
Therefore, the detailed signaling and molecular profiling involved
in detachment induced stem-like potential holds exceptional
promise to develop metastasis-tailored therapies.
Recently, the concept of phenotypic plasticity in cancer cells
has been well established. Several studies confirmed that both
CSCs and non-CSCs were capable of undergoing phenotypic
transitions in response to microenvironmental stresses, with
a dynamic equilibrium of dedifferentiation-redifferentiation
between non-CSCs and induced CSCs (Batlle and Clevers, 2017;
O’Brien-Ball and Biddle, 2017; May et al., 2018; Clarke, 2019).
Specifically, non-CSCs can be induced or dedifferentiate into
induced CSCs by radio-chemotherapy (Peitzsch et al., 2016; Chen
et al., 2017) and also by detachment condition, as shown in this
paper. As we prepared this manuscript for publication, Fumagalli
et al. (2020) reported that Lgr5− non-CSCs are able to convert
into Lgr5+ CSCs at the metastatic site for efficient colorectal
cancer metastatic outgrowth. Based on these finding, it seems
that a successful cancer cure can be achieved only by killing both
preexisting CSCs and induced CSCs. The key point to eradicate
the induced CSCs is to prevent the formation of induced CSCs
and to block the signaling pathways involved in de-differentiation
of non-CSCs to CSCs. Thus, blocking the detachment of cancer
cells from the ECM and the subsequent induction of CSC
potential could be a novel strategy for therapeutic intervention
of cancer metastasis.
Due to their plasticity, CSCs will always be activated
or recreated on the condition that the CSC niche remains
intact. Thus, a better understanding of the underlying genetic
and epigenetic factors in the niche where cancer cells adopt
phenotypic plasticity could help us to effectively control cancer
progression and recurrence (O’Brien-Ball and Biddle, 2017).
For example, a cancer pre-metastatic niche, like the MPE, may
function as a dynamic reservoir for invasive cancer cells, where
cancer cells may establish a malignant cytokine network for
their survival and metastasis (Giarnieri et al., 2015; Bruschini
et al., 2020). In our current study, we revealed that the
levels of eCyPA in the conditioned medium of detachment
cultured cells were significantly higher than that in cells
growing under the attached condition; while the addition of
recombinant CyPA promoted the conversion of cancer cells
to CSCs in a CD147-dependent manner. Previous studies
showed that IL-6 can induce conversion of non-CSCs to
CSCs (Iliopoulos et al., 2011; Kim et al., 2013), but we did
not detect any increases in IL-6 levels in our experimental
conditions (data not shown). Although cytoplasmic CyPA is
reported to play a role in maintaining glioma CSC stemness
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(Wang et al., 2017), our study is the first report of such effort to
focus on the effects of extracellular secreted CyPA on induction
of CSC potential. Unfortunately, it remains unknown how and
why non-CSCs were able to produce eCyPA and overexpress
CD147 upon detachment. Future studies are needed to identify
the upstream signaling cascade that triggers the expression and
activation of eCyPA and CD147 in breast cancer cells growing
under the detached condition.
Previous studies revealed that high CD147 expression on
cancer cells is linked to CSC characteristics, such as EMT,
anoikis-resistance, and chemoresistance (Ma et al., 2010; Wu
et al., 2011; Ke et al., 2012; Dai et al., 2013), indicating that
cancer cells expression high levels of CD147 could be more
aggressive and prone to cancer metastasis and recurrence. Indeed,
our previous findings indicated that anti-CD147 HAb18IgG
sensitized pancreatic cancer cells to chemo-radiotherapy and
reduced CSC potential by inhibiting pSTAT3 signaling (Fan
et al., 2019), and the CD147 antibody drug, namely, Licartin,
was successfully used to prevent tumor recurrence after
liver transplantation or radiofrequency ablation in advanced
hepatocellular carcinoma patients (Xu et al., 2007a; Bian
et al., 2014). Here, we demonstrate that CD147 expression
on breast cancer cells was upregulated when culturing cells
under a detached condition, and CD147 expression boosted
the detachment-induced conversion of non-CSCs to CSCs
by activating STAT3-SOX2 signaling. In this regard, blocking
circulating breast cancer cells with an anti-CD147 antibody
could be clinically effective at suppressing the induced CSCs
(or MICs), and subsequently preventing the generation of
metastatic tumor mass.
CONCLUSION
In summary, our current study demonstrates that detachment
induced breast cancer cells to express CD147 and secrete CyPA,
which played an important role in the conversion of non-
CSCs to CSCs through activation of the STAT3-SOX2 signaling
pathway (Figure 6H). Thus, our findings uncovered a pivotal
role of the eCyPA-CD147 axis in the functional link between
anoikis resistance and induced CSC potential. The translational
extension of these studies into the clinical setting could include
the development of novel therapies of breast cancer metastasis by
targeting the eCyPA–CD147 interaction.
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